Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ASND
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Ascendis Pharma A/S (ASND) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Ascendis Pharma (ASND) trades at $225.60, down 2.21% in the last session, with a bearish technical signal but strong analyst support. The stock shows robust revenue growth, with Q2 2026 product revenue up 105% year-over-year to €315 million, and a net income margin of 70.84% projected for 2026. Recent developments include a $400 million share repurchase program and regaining rights to TransCon technology, though negative equity and high debt-to-asset ratios of 66.92% in 2025 pose risks.
Outlook is mixed: analyst consensus is strongly bullish with a $317.42 price target, but technical indicators signal near-term bearishness. Key opportunities include pipeline expansion and strong product sales growth, while risks involve debt levels and execution challenges. Investors should weigh fundamental strength against volatility and leverage concerns.
Read full analysis

Key Stats

  • Market Cap
    $14.85B
  • Volume
    419,974
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $191.60
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $14.44B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$230.06
52W Low: $191.6
29 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $191.6 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

Most Recent News

Content is generated by Aura AI

Robinhood shifts focus from trading to becoming customers' main financial platform.

Robinhood is evolving from just a trading platform to a primary financial hub where customers keep and manage more of their money. The company's long-term success depends on deepening customer engagement beyond stock trades, encouraging users to entr...

Market News
4 hours ago
Seeking Alpha
Neutral
Robinhood shifts focus from trading to becoming customers' main financial platform.

New Amalga Gold Project's federal permitting timetable officially posted, advancing regulatory process.

Grande Portage Resources announced that the official federal permitting timetable for its New Amalga Gold Project in Southeast Alaska has been posted on the Federal Permitting Dashboard under the FAST-41 program. This milestone marks a key step in th...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
New Amalga Gold Project's federal permitting timetable officially posted, advancing regulatory process.

Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.

Poolbeg Pharma has secured funding to complete its clinical trials through to the second quarter of 2028. The company is currently recruiting patients for its TOPICAL trial of POLB 001, a drug aimed at preventing cytokine release syndrome in cancer p...

Market News
5 hours ago
Proactive Investors
Bullish
news icon
Poolbeg Pharma funds trials through 2028, advancing cancer and obesity drug studies.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $14.85B
  • Volume
    419,974
  • Sector
    Health
  • 52W High
    $277.18
  • 52W Low
    $191.60
  • Typical Hold Time
    55 Days
  • Enterprise Value
    $14.44B
  • Div Yield
    -
  • Trading Activity
    0% Sell | 100% Buy
$230.06
52W Low: $191.6
29 Sep 2025
52W High: $277.18
08 Jul 2026

Track Ascendis Pharma A/S (ASND) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Ascendis Pharma A/S has traded between a low of $191.6 and a high of $277.18, highlighting its annual price range. Buy and sell Ascendis Pharma A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!